# Kura Oncology, Inc. (KURA): MoatMap facts

As of 19 Nov 2026. Research data, not investment advice.

As of 19 Nov 2026, the MoatMap Score for Kura Oncology, Inc. (KURA) is 5/100, ranked against 25,000+ stocks in 38 markets (Quality 14, Value 22, Momentum 36, each scored against its sector).

- MoatMap Score: 5/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 14, Value 22, Momentum 36: each a 0-100 percentile within Healthcare.
- Position: #25,238 overall, #2,499 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 7.34 USD on 18 Nov 2026.
- Insider filings, last 180 days: directors bought USD 3.9M; directors sold USD 2.5M.

Source: https://moatmap.ai/stock/KURA
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
